NYSE:UNH News 2 December 2025 - 20 December 2025

NEW YORK — December 19, 2025 (after the close) — UnitedHealth Group Incorporated (NYSE: UNH) finished Friday’s session close to flat after a sharp, headline-driven swing, then drifted modestly in after-hours trading. Two stories dominated the tape into the closing bell: (1) President Donald Trump’s fresh push for insurers to cut prices/premiums, and (2) UnitedHealth’s release of early findings from an independent review program that laid out 23 operational “action plans” and a timeline into early 2026. Reuters+2UnitedHealth Group+2 Because U.S. markets are closed on Saturday and Sunday, the “next open” after Friday’s close is Monday, December 22, 2025—meaning the

UnitedHealth Group Incorporated (NYSE: UNH) stock is ending a volatile 2025 with fresh headline risk—and a handful of potentially meaningful catalysts—front and center on December 18, 2025. Shares traded around $326–$327 in midday trading, after moving between roughly $324.66 and $330.50 intraday. While UnitedHealth remains one of the most closely watched blue-chip healthcare names, 2025 has been defined by unusually wide investor debate about near-term earnings durability, regulatory risk, and the pace of normalization into 2026. By one Reuters-tracked measure, UNH’s year-to-date price return is roughly -32.6%—a drop that helps explain why even incremental “good news” headlines can move the

UnitedHealth Group Incorporated (NYSE: UNH) is ending Wednesday’s session on a cautious note, with shares slipping further after the closing bell as investors weigh a major investigative report, a risk-off tape in U.S. equities, and a busy macro calendar set to hit before Thursday’s open. Below is what matters after the bell on December 17, 2025, and what to keep on your radar before the market opens Thursday, December 18, 2025. UNH stock price after the bell: where shares stand tonight In extended trading, UNH dipped modestly below the regular-session close: Zooming out, UNH remains far off its highs: Investing.com

December 16, 2025 UnitedHealth Group Incorporated (NYSE: UNH) is back in focus for investors as the health insurance giant heads into a catalyst-heavy stretch: a dividend payment landing today, a confirmed date for full‑year 2025 results and 2026 guidance, and a drumbeat of regulatory and legal headlines tied to its Optum business and Medicare-related scrutiny. As of 15:44 UTC on Dec. 16, UNH shares were trading around $337.21, down about 1.14% on the session. Investors tracking intraday action saw UNH trade within a relatively tight band early Tuesday, with one real-time quote showing a day’s range near $335.54 to $340.99.

UnitedHealth Group Incorporated (NYSE: UNH) finished the week with a notable rebound, closing Friday, December 12, 2025 at $341.84, up 1.52% on the day—outperforming a broader market that sold off into the weekend. Investing.com+1 The move capped a choppy five-session stretch that began with a sharp Monday drop and then reversed higher for most of the week—while investors weighed a fast-moving mix of antitrust developments, opioid litigation headlines, and Washington policy risk that can hit managed-care sentiment quickly. Investing.com+2Department of Justice+2 UNH stock price action: where UnitedHealth ended the week UNH ended Friday at $341.84 (open $337.50, high $344.98, low

UnitedHealth Group Incorporated (NYSE: UNH) has been at the center of one of 2025’s biggest blue‑chip storylines: a brutal share-price collapse, a messy reset in Medicare Advantage, a Department of Justice (DOJ) probe, credit‑rating downgrades, and now a tentative turn toward recovery. Since November 21, 2025, a fresh wave of news, forecasts, and opinion pieces has reshaped how investors view UNH stock. Below is a structured, Google‑News‑friendly rundown of what’s happened from November 21, 2025 through today (December 11, 2025), what Wall Street expects for 2026, and what risks still hang over the story. UNH Stock Snapshot as of December

UnitedHealth Group (NYSE: UNH) stock is trading in the low‑$300s after a year of surging medical costs, a record‑breaking cyberattack and fresh DOJ scrutiny. With raised 2025 EPS guidance, a 2.7% dividend yield and Wall Street seeing mid‑teens upside, is UNH setting up for a 2026 recovery—or more pain? Quick snapshot (as of December 8, 2025) UnitedHealth (UNH) stock today: price, performance and ex‑dividend date UnitedHealth Group remains one of the most important stocks in the U.S. health‑care ecosystem and a heavyweight in the Dow Jones Industrial Average. But 2025 has been a punishing year. Today is also a key

Published: December 7, 2025 UnitedHealth Group Incorporated (NYSE: UNH) heads into Monday’s U.S. session still in “repair mode” after one of the most bruising years in its modern history. Yet fresh analyst upgrades, stabilizing fundamentals and a key dividend date on December 8, 2025 mean the stock could be more active than usual at the open. Below is a concise, news-driven briefing on UnitedHealth stock before the market opens on December 8 – based on the latest coverage, forecasts and analyses through December 7, 2025. 1. UnitedHealth stock snapshot heading into December 8 For context, Investing.com and FinanceCharts both highlight

UnitedHealth Group Incorporated (NYSE: UNH) is back under intense scrutiny from Wall Street and regulators after one of the most turbulent stretches in its history. As of Thursday, December 4, 2025, UNH stock is trading around $333–340 per share, giving the company a market capitalization just over $300 billion and leaving the shares more than 45% below their 12‑month high near $623. MarketBeat+1 The past year has brought a catastrophic cyberattack, a criminal and civil investigation by the U.S. Department of Justice (DOJ), a leadership shake‑up that saw longtime executive Stephen Hemsley return as CEO, and the shocking killing of

New York – December 4, 2025 – UnitedHealth Group Incorporated (NYSE: UNH) has turned into one of Wall Street’s most closely watched recovery stories. After losing nearly half its value earlier this year, the stock is rallying hard into year‑end as management raises guidance, exits non‑core businesses and analysts upgrade their price targets ahead of an expected earnings rebound in 2026. StockAnalysis+2UnitedHealth Group+2 Below is a detailed look at where UNH stock stands today, what has changed in the business, how analysts are modeling the next few years, and the key risks investors are watching. UNH stock today: price, performance